Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

Bioextrax: Capacity to accommodate rising interest - VH Corp

Bioextrax

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* American start-up company exercises option for the next period
* Warrants subscription adds SEK 10.6 million before issue costs
* Our model implies a fair valuation of SEK 10.5 per share

Bioextrax shows continued progress in its Q2 report for 2023. The company
signed a license agreement with the US start-up, replacing the term sheet from
earlier this year. Bioextrax project with the cosmetics company has also made
progress entering phase three in the process. Initial runs in Bioextrax
scaled-up facility are completed, giving the company the capacity to
accommodate a rising customer interest. Bioextrax is in dialogue with several
counterparts, discussing the next step after successful tests and evaluations.
The company’s progress resulted in minor changes in our model, and we maintain
the fair value of SEK 10.5 per share.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team